Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
10/30/14 Neurocrine (NBIX) NBI-98854 for Tardive Dyskinesia Subscribers Only Subscribers Only Subscribers Only
10/30/14 Bristol-Myers Squibb (BMY) Opdivo for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
10/30/14 AstraZeneca (AZN) Xigduo XR for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
10/29/14 Pfizer (PFE) Trumenba for Meningococcal Vaccines and Other Meningococcus-Specific Agents (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
10/29/14 Cara Therapeutics (CARA) CR845 for Postsurgical Pain Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
10/30/14 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
Now - 10/31/14 Subscribers Only Subscribers Only Trial Announcement - Initiation
Now - 10/31/14 Subscribers Only Subscribers Only Trial Announcement - Initiation
Now - 10/31/14 Subscribers Only Subscribers Only Trial Announcement - Initiation
Now - 10/31/14 Subscribers Only Subscribers Only Trial Announcement - Initiation